Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Nvidia (NVDA) CEO Jensen Huang took to the stage Tuesday afternoon to deliver his keynote speech at the chip giant's 2025 GTC event (GPU Technology Conference), where he previewed the company's ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

After hours: March 18 at 7:22:36 PM EDT Loading Chart for VRTX ...

Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo, São Paulo 05403-000, Brazil LIM-46 HC-FMUSP − Laboratory of Medical Investigation, Clinical Hospital, Faculty ...

You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters ...

After hours: March 17 at 7:55:50 p.m. EDT ...